KALV - KalVista Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (3Y Monthly) 1.59
52-Week Change 3-43.36%
S&P500 52-Week Change 37.98%
52 Week High 334.92
52 Week Low 39.86
50-Day Moving Average 313.61
200-Day Moving Average 319.33

Share Statistics

Avg Vol (3 month) 3132.97k
Avg Vol (10 day) 3294.08k
Shares Outstanding 517.82M
Float 9.72M
% Held by Insiders 110.43%
% Held by Institutions 178.57%
Shares Short (Sep 30, 2019) 4866.66k
Short Ratio (Sep 30, 2019) 48.93
Short % of Float (Sep 30, 2019) 46.93%
Short % of Shares Outstanding (Sep 30, 2019) 44.86%
Shares Short (prior month Aug 30, 2019) 4883.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 214/1
Last Split Date 3Nov 22, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr 30, 2019
Most Recent Quarter (mrq)Jul 31, 2019


Profit Margin -146.56%
Operating Margin (ttm)-205.19%

Management Effectiveness

Return on Assets (ttm)-22.80%
Return on Equity (ttm)-36.10%

Income Statement

Revenue (ttm)15.78M
Revenue Per Share (ttm)0.94
Quarterly Revenue Growth (yoy)-9.40%
Gross Profit (ttm)-18.89M
EBITDA -31.93M
Net Income Avi to Common (ttm)-23.12M
Diluted EPS (ttm)-1.38
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)100.37M
Total Cash Per Share (mrq)5.63
Total Debt (mrq)1.76M
Total Debt/Equity (mrq)1.73
Current Ratio (mrq)8.28
Book Value Per Share (mrq)5.72

Cash Flow Statement

Operating Cash Flow (ttm)-41.43M
Levered Free Cash Flow (ttm)-34.11M